MANCHESTER, NH -- (Marketwired) -- 08/13/15 -- Boston Therapeutics, Inc. (OTCQB: BTHE), a leading developer of novel compounds based on complex carbohydrate chemistry for the treatment of diabetes and inflammatory disease, today reported its financial results for the second quarter and six months e ...
↧